The liver has long been described as immunosuppressive, although the mechanisms underlying this phenomenon are incompletely understood. Hepatic stellate cells (HSCs), a population of liver nonparenchymal cells, are potent producers of the regulatory T cell (Treg)-polarizing molecules TGF-b1 and all-trans retinoic acid, particularly during states of inflammation. HSCs are activated during hepatitis C virus infection and may therefore play a role in the enrichment of Tregs during infection. We hypothesized that Ag presentation in the context of HSC activation will induce naive T cells to differentiate into Foxp3 + Tregs. To test this hypothesis, we investigated the molecular interactions between murine HSCs, dendritic cells, and naive CD4 + T cells. We found that HSCs alone do not present Ag to naive CD4 + T cells, but in the presence of dendritic cells and TGF-b1, preferentially induce functional Tregs. This Treg induction was associated with retinoid metabolism by HSCs and was dependent on all-trans retinoic acid. Thus, we conclude that HSCs preferentially generate Foxp3 + Tregs and, therefore, may play a role in the tolerogenic nature of the liver.
T he consequences of the immunosuppressive nature of the liver likely extend to phenomena as diverse as oral tolerance, liver transplant tolerance, and potentially the dysfunction of the T cell compartment in chronic hepatotropic infections, such as hepatitis B and C viruses (HBV and HCV, respectively). However, the mechanisms underlying liver-associated immunosuppression are not well understood. The role of the liver in oral tolerance is highlighted by two key observations: 1) oral tolerance is dependent on blood flow from the intestine to the liver (1), and 2) can be mimicked by direct Ag delivery via the portal vein (2) (3) (4) (5) . Importantly, oral tolerance may be specifically mediated by the regulatory T cell (Treg) subset (6, 7) , indicating a role for tolerogenic interactions between liver APCs and T cells. The tolerogenic nature of the liver also impacts liver transplantation, which can be performed without extensive histocompatibility matching or harsh immunosuppressive regimens, indicating a role for T cell-based tolerance in concert with other well-described, nonadaptive regulatory mechanisms such as immunosuppressive cytokines (8) . Liver-associated T cell tolerance may also play a major role in the inability to clear HBV and HCV infections, which are associated with expanded Treg populations in the blood and liver (9) (10) (11) (12) (13) (14) (15) .
We therefore postulated that Ag presentation in the liver might play a role in the suppression of intrahepatic T cell responses through the induction of Tregs. Recent studies have highlighted the differential ability of various APCs to induce differentiation of the distinct lineages of CD4 + T cells (reviewed in Refs. [16] [17] [18] . Upon interaction with APCs displaying the cognate Ag, naive CD4 + T cells have the potential to differentiate into multiple distinct lineages: 1) IFN-g-producing TH1 primed in the presence of IL-12; 2) IL-4-, IL-5-, and IL-10-producing TH2 cells primed in the presence of IL-4 or IL-5; 3) IL-17-producing TH17 cells primed in the presence of TGF-b1 and IL-6; and 4) Tregs capable of inhibiting proliferation and cytokine production in other T cells are primed in the presence of TGF-b1 and all-trans retinoic acid (ATRA) (16) (17) (18) . In particular, some gut-derived APCs specifically prime naive CD4 + T cells to become Foxp3 + Tregs in a TGFb1-and ATRA-dependent manner (7, (19) (20) (21) .
Ag presentation to CD4 + T cells in the liver can be mediated by multiple cell types, including professional APCs such as liverresident dendritic cells (DCs) and Kupffer cells (KCs), the liverresident macrophages, and is reported to extend to other cells including liver sinusoidal endothelial cells (LSECs) (22) and hepatic stellate cells (HSCs) (23) . Liver DCs, KCs, and LSECs have been extensively studied for their Ag-presentation capacity and priming of CD4 + T cells. DCs resident in the liver are immature and produce IL-10 and prime TH2 responses (24) , but when activated produce IL-12, priming a TH1 response (25) . Similarly, KCs alternatively produce IL-12 or IL-10 in response to different stimuli and, therefore, can prime TH1 or TH2 responses (26, 27) . LSECs can induce CD4 + T cell division but inhibit TH1 differentiation (28) and have long been associated with the tolerogenic nature of the liver (29) . This effect was recently demonstrated to be mediated by coinhibitory signals delivered by the interaction of PD-1 on the T cell with PD-L1 on the LSEC (30) . HSCs were found to express low levels of MHC class II and the costimulatory molecules CD80 and CD86, but have only recently been described to stimulate CD4 + T cells in an Ag-specific manner (23 Interestingly, HSCs have been associated with the production of both ATRA and TGF-b, each a requirement for Treg differentiation. HSCs are the primary storage cell for retinol, or vitamin A (32), which is metabolized to ATRA during activation (33) , and activated HSCs have also been shown to produce TGF-b1 (32) . Recent reports have demonstrated that HSCs do indeed influence Treg differentiation, but only in trans with strong DC stimulation, adding confusion to the field (34) . We therefore tested whether HSCs can influence naive CD4 + T cell differentiation into Tregs, either directly or indirectly, using a murine system. We found that highly purified HSCs were unable to induce proliferation and cytokine production in naive OT-II transgenic T cells directly. In coculture with DCs and low concentrations of TGF-b1, however, HSCs preferentially induced the expression of Foxp3 in CD4 + T cells. Importantly, this Treg development was dependent on HSC production of ATRA, as antagonism of retinoic acid receptor a (RARa) signaling inhibited the upregulation of Foxp3 on naive OT-II T cells. Thus, we conclude that HSCs preferentially induce Treg differentiation during priming in an ATRA-dependent manner. This finding may provide a mechanism for the tolerogenic nature of the liver and the expansion of Tregs during HBV and HCV infections.
Materials and Methods

Animals
C57BL/6 and BALB/c mice (The Jackson Laboratory, Bar Harbor, ME) and OT-II mice, with a TCR transgene specific for OVA peptides 323-339, on the C57BL/6 background were maintained in accordance with Association for Assessment and Accreditation of Laboratory Animal Care and Institutional Animal Care and Use Committee guidelines.
Liver cell isolation
HSCs were isolated from liver of C57BL/6 mice by perfusion with HBSS, then 0.4% protease (Sigma-Aldrich, St. Louis, MO), followed by 0.01% collagenase (Sigma) solutions in DMEM/F12 medium. After gentle mechanical disruption, the resulting suspension was incubated at 37˚C in a 0.4% collagenase solution in DMEM/F12 with 0.5 mg/ml DNAse for 20 min. The digested suspension was filtered through 70-mm mesh and centrifuged 50 3 g for 3 min. The supernatant was then centrifuged and resuspended in 20% Optiprep (Sigma-Aldrich) diluted in HBSS and overlaid with 11.2% Optiprep, then overlaid with HBSS and centrifuged 1400 3 g for 17 min. HSCs were harvested from the interface of 11.2% and HBSS layers, and were washed twice with complete RPMI 1640 with penicillin, streptomycin, and amphotericin B (Lonza, Basel, Switzerland). Splenic DCs were isolated using the CD11c microbeads kit for mouse (Miltenyi Biotec, Bergish Gladbach, Germany).
UV autofluorescence-based sorting of HSCs
After density gradient enrichment, liver nonparenchymal cells were stained with Abs to CD146 (FITC, ME-9F1; Miltenyi Biotec), CD45 (PerCP-Cy5. 5 DCs, or both (1:1 ratio), in the presence of OVA peptide 323-339 (10 mg/ ml) and recombinant mouse TGF-b1 at various concentrations. In some conditions, ATRA (100 nM; Sigma-Aldrich) and/or LE540 (1 mM; Wako Pure Chemical Industries, Osaka, Japan) were used as indicated for the duration of the culture. When using UV-sorted cells, HSC inputs were limited to 2 3 10 4 cell/well. After 90 h, the OT-II T cells were stained for Foxp3 expression using the PE anti-mouse/rat Foxp3 staining set (eBioscience, San Diego, CA). For transwell experiments, naive OT-II T cells, splenic DCs, and HSCs (either HSCs or DCs were separated by transwell insert as indicated) were cocultured for 90 h in the presence of OVA and TGF-b1.
Intracellular cytokine staining
In vitro cultured OT-II cells were restimulated in an anti-CD3 (clone 145-2C11)/anti-CD28 (clone 37.51; BD Biosciences, San Jose, CA)-coated plate for 4 h in the presence of brefeldin A and monensin, and stained with Abs to Foxp3 (PE, FJK-16s; eBioscience), IL-17 (allophycocyanin, eBio17B7; eBioscience), CD4 (PECy7, GK1.5; eBioscience), and IFN-g (PE, XMG1.2; BD Biosciences). Stained cells were acquired using an LSRII (BD Biosciences) and analyzed using FlowJo (Tree Star, Ashland, OR). 
Microscopy
HSCs were plate activated for 7 d, then trypsinized and replated on chambered glass slides for adherence overnight. The cells were then fixed with 4% paraformaldehyde, permeabilized with 0.1% Triton X-100 in PBS, and stained with mouse anti-GFAP mixture (BD Biosciences) and rabbit a-SMA (E184; Novus Biologicals, Littleton, CO), followed by goat antimouse Ig (Alexa Fluor 488; Invitrogen, Burlingame, CA) and goat antirabbit Ig (Alexa Fluor 647; Invitrogen). Images were acquired using a Zeiss Axioscope Z.1. For autofluorescence microscopy, isolated cells were plated on nontissue culture-treated plates, and images were collected in phase-contrast bright field and under UV excitation.
RT-PCR
RNA was prepared from the indicated cell populations using the RNeasy Mini Kit (Qiagen, Valencia, CA) and cDNA synthesized using the FirstStrand cDNA Synthesis kit using SuperScript II RT with random primers (Invitrogen). cDNA was used as a template for quantitative real-time PCR using SYBR Green Master Mix (BioRad) and the following primers: (all 59→39) Gapdh sense: TGGCAAAGTGGAGATTGTTGCC; Gapdh antisense: AAGATGGTGATGGGCTTCCCG; Aldh1a1 sense: ATGGTTTA-GCAGCAGGACTCTTC; Aldh1a1 anti-sense: CCAGACATCTTGAATC-CACCGAA; Aldh2a1 sense: GACTTGTAGCAGCTGTCTTCACT; Aldh2a1 anti-sense: TCACCCATTTCTCTCCCATTTCC. PCR and analysis were performed using a MyiQ iCycler (BioRad). Gene expression was calculated relative to Gapdh.
Results
HSCs 32) . Subsequent immunofluorescence staining for GFAP, a molecule expressed in the liver only by HSCs, and a-SMA, upregulated by activated HSCs, indicated that the isolated cells were indeed HSCs (Fig. 1A) . To understand whether HSCs can act directly as APCs to induce Ag-specific proliferation of naive CD4 + T cells, we enriched HSCs from the liver of a C57BL/6 mouse and cocultured these cells in combination with naive CD4 + T cells from an OT-II transgenic mouse in the presence of OVA peptides 323-339. In the representative experiment shown, HSCs did not stimulate the proliferation of naive CD4 + T cells, whereas splenic DCs strongly stimulated T cell proliferation (Fig. 1B) . Thus, under these conditions, we found that HSCs were incapable of directly inducing proliferation in naive CD4 + T cells in an Agspecific manner.
HSCs influence DC-primed T cells to differentiate into Foxp3
+ Tregs
Because HSCs did not prime T cells directly in this system, we asked whether HSCs could influence the DC-induced differentiation of T cells. To this end, we isolated naive OT-II T cells and stimulated them with cognate Ag in the presence of HSCs, splenic DCs, or HSCs and splenic DCs combined. We detected minimal Foxp3 expression in OT-II T cells cultured with HSCs (3%) or DCs (4%) alone, or from the HSC+DC coculture (4%; Fig. 2A ). The addition of exogenous TGF-b1 induced a significant fraction of the CD4 + T cells derived from HSC+DC coculture to express Foxp3 (18% at 1 ng/ml), whereas no Foxp3 induction was observed in the absence of exogenous TGF-b1 ( Fig. 2A) . With the addition of exogenous TGF-b1, Foxp3 induction was observed in OT-II cells cultured with splenic DCs, but importantly, a significantly higher fraction of the OT-II T cells expressed Foxp3 (18%) when HSCs were also present. This demonstrated that HSCs had a positive influence on Treg development in this culture. To test whether this observation would hold true for liver-resident CD4 + T cells, which may respond differently to the stimulation conditions, we performed similar coculture experiments using intrahepatic OT-II T cells and assessed the HSC-mediated effects in these cultures. We found that the level of Foxp3 inductions for liver-resident CD4 + T cells during priming was comparable with that observed for splenic CD4 + T cells (Fig. 2B) , and that this expression was also positively influenced by the presence of HSCs. Although the addition of a low concentration of TGF-b1 induced a significant fraction of the OT-II T cells derived from HSC+DC coculture to express Foxp3, DCs alone were only able to prime a small fraction of Foxp3 + cells at very high TGF-b1 concentration (10 ng/ml; Fig. 2C ).
In addition, we also analyzed the expression of key molecules associated with other major lineages of CD4 + T cells: IFN-g (TH1), IL-10 (TH2), and IL-17 (TH17). IFN-g, IL-17, and IL-10 were measured after restimulation of cells cocultured with HSCs and DCs under the same conditions. We observed induction of IFN-g expression indicative of TH1 cells only in OT-II cells cultured with DC, which was inhibited by the addition of TGF-b1 (Fig. 2D) . IL-17 expression was minimal and expressed only by OT-II cells cultured with DCs in the highest TGF-b1 concentrations (data not shown). IL-10 production by OT-II cells was not detected under any conditions (data not shown). These findings demonstrated that although HSCs alone were not capable of directly priming naive CD4 + T cells, they could induce Treg differentiation during priming by professional APC.
Treg induction by HSC is MHC independent
To confirm that HSCs do not function as APCs directly, we separated the Ag-presenting capacity of HSCs and DCs in the coculture system in two experiments. First, we isolated these -expressing APCs from C57BL/6 mice are capable of presenting OVA. Importantly, when HSCs from BALB/c mice and DCs from C57BL/6 mice were used in the coculture experiment, we observed Foxp3 expression despite being cultured with HSCs incapable of presenting cognate Ag (Fig. 3A) , although, reciprocally, when only HSCs expressed I-A b , proliferation and expression of Foxp3 was not observed (Fig. 3B) . Second, we separated HSCs or DCs (both from C57BL/6 mice) from CD4 + T cells using transwell inserts. If we separated DCs from the HSCs and CD4 + T cell culture by transwell insert, we found no T cell priming, similar to HSCs and CD4 + T cells alone. However, significant Foxp3 induction was observed when HSCs were separated from the DCs and CD4 + T cell coculture (Fig. 3C) . Together, these data confirm that HSCs can modify naive T cell priming by DCs and demonstrate that this influence is mediated by soluble factors.
Foxp3
+ Treg induction is specific to HSCs, not other liver-resident cells
The enrichment technique used earlier results in enrichment of HSCs, but not a purified population. To confirm that the phenomena observed earlier were due to HSCs and not a contaminating cell population, we purified HSCs after enrichment using FACS cell sorting based on vitamin A-mediated UVAF (35) (36) (37) . HSCs were identified as UVAF + and lacking the expression of LSEC marker CD146 and hematopoietic cell marker CD45 (Fig. 4A) . Other liver-resident APCs could also be identified, based on their expression of markers such as CD146 (LSEC), F4/80 (KC), and CD11c (DC; Fig. 4A ). To confirm that the isolated UVAF + cells were HSCs, we measured expression of GFAP and a-SMA by flow cytometry and found that UVAF + HSCs expressed elevated levels of GFAP and a-SMA compared with other nonfluorescent liver cells and splenocytes (Fig. 4B) . Importantly, the freshly isolated UVAF + HSCs did not express MHC class II, consistent with the observation that the HSCs cannot directly prime CD4 + T cells (Fig. 4B) . After the identification and phenotyping of HSCs and the various liver-resident APC populations, we tested the influence of these populations on Treg differentiation. To this end, we cultured the sorted HSCs, LSECs, KCs, and liver DCs with naive OT-II cells, splenic DCs, TGF-b, and cognate Ag as described earlier. Consistent with our previous observations, pure populations of UVAF + HSCs resulted in Foxp3 induction in the context of DC priming and TGF-b1, whereas none of the other liver-derived subsets were capable of inducing Foxp3 induction (Fig. 4C) .
HSCs metabolize retinoids to form retinoic acid during activation
We found earlier that HSCs can influence DC-mediated naive CD4 + T cell priming to induce Tregs through a soluble factor. ATRA signaling through RARa has been recently described to be important for the development of Tregs (20, (38) (39) (40) (41) . Because HSCs are the major storage cell for retinol (vitamin A), the metabolic precursor of ATRA (32) , and this retinol is lost during the activation program (33), we hypothesized that HSCs produce ATRA, and that this ATRA promotes Treg differentiation during T cell priming. We therefore investigated the production of ATRA by HSCs in our system. We first measured the expression of the key enzymes in the generation of ATRA. Retinol is initially converted to retinaldehyde by retinol dehydrogenases, which is subsequently converted, in the rate-limiting and irreversible step, to ATRA by the retinaldehyde dehydrogenases RALDH1 and RALDH2 (ALDH1A1 and ALDH1A2, respectively). We isolated RNA from HSCs directly after isolation or after 3 or 7 d of plate activation, as well as from freshly isolated splenic DCs, and used sequence-specific primers to perform quantitative RT-PCR to measure the expression of the rate-limiting RALDH1 and RALDH2. We found that plate activation of HSCs, which mimics in vivo activation (32), induced expression of both RALDH1 and RALDH2 (Fig. 5A ) compared with minimal expression in splenic DCs. We then measured cellular retinoid content qualitatively in plate- activated HSCs by UV fluorescence microscopy. UV-excited retinoid compounds exhibit a characteristic, rapidly fading fluorescence, detectable in isolated HSCs and in whole liver sections (42) . We found that over the course of activation, HSCs greatly increase in size, differentiate into fibroblast-like cells, and lose the retinoidspecific UVAF (Fig. 5B, 5C ). Importantly, the kinetics of RALDH1 and RALDH2 upregulation coincided with the loss of retinoid content in plate-activated HSCs as measured by UVAF.
ATRA production by HSCs during activation is essential for HSC-mediated Treg differentiation
To confirm that the ATRA produced by HSCs plays a role in Treg priming, we first confirmed that RA alone could induce Tregs during DC priming (Fig. 6) . We then prevented interaction of RA with RARa during coculture of naive OT-II T cells with HSCs and DCs using the RARa-specific antagonist LE540. We found that the HSC-induced Foxp3 expression was strongly inhibited by LE540 (Fig. 6) , supporting the hypothesis that HSC-derived ATRA is responsible for the HSC-specific induction of Treg differentiation.
Discussion
Basic mechanistic explanations for the observed tolerogenic nature of the liver have been elusive, despite decades of study. Although nonadaptive mechanisms such as constitutive immunosuppressive cytokine expression have been well documented (8) , tolerance of the adaptive immune system in the liver is likely not global, but rather Ag-specific and mediated by Treg (6) . However, it is not known how the liver generates Tregs. We hypothesized that a subset of hepatic cells may be directly or indirectly responsible for the differentiation of Tregs. Multiple cell types in the liver are reported to be capable of presenting Ag to CD4 + T cells: liver DC (24, 25) , KC (26, 27) , LSEC (22) , and HSC (23) . Because HSCs are the major storage site for retinol, the metabolic precursor for ATRA, and produce the key Treg-polarizing molecules ATRA and TGF-b1 during activation, we focused our studies on the molecular interactions of HSCs with naive CD4 + T cells. Using naive CD4 + T cells derived from the OTII strain of TCR transgenic mice, we found that HSCs alone were unable to induce proliferation and differentiation, although in the presence of DC and low concentrations of exogenous TGF-b1, upregulation of Foxp3 was observed from the naive CD4 + T cells during division. This finding confirms the findings by Ichikawa et al. (34) that HSCs indirectly prime DC-activated Tregs. This process was dependent on signaling through RARa and was associated with loss of HSC cellular retinoid content and concomitant upregulation of RALDH1 and RALDH2. Thus, we conclude that HSCs skew Th cell differentiation toward Tregs in a TGF-b1-and ATRAdependent manner.
Treg conversion by HSCs, under the conditions reported in this study, is dependent on the addition of exogenous TGF-b, despite the previous descriptions of direct TGF-b production by HSC. This finding is likely due to the synchronicity of HSC activation in our coculture system, where all HSCs are at similar activation states. Thus, in our culture conditions, there does not exist a population of fully activated HSCs that have attained maximum TGF-b1 production (32) . Such a population would be expected among an asynchronously activated HSC population observed in vivo, where HSCs would exist at various states of activation at any given time. In addition, other cells in the liver constitutively produce TGF-b1, including LSEC (43) and KC (44) , indicating that TGF-b1 from other cells may act in concert with HSCs to induce Treg. We have established that ATRA is likely produced by HSCs in our coculture experiments by demonstrating a dependence of Foxp3 induction in naive T cells on RARa signaling, as well as showing that the retinoid content of HSCs is lost during in vitro activation concomitant with the induction of RALDH1 and RALDH2 expression. In addition, other groups have confirmed ATRA production by activated HSCs using HPLC (33) . In vivo, other cytokines produced in the liver can also induce Treg priming and may act in concert with HSC-derived TGF-b1 and ATRA, such as LSEC-or KC-derived IL-10 (45, 46) . In addition, KCs can induce Tregs through other mechanisms, such as galectin-9 expression (47) .
These findings demonstrate a potential mechanism for the generation of Tregs within the liver environment and define a role for HSC:CD4 + T cell interactions in liver immune tolerance. The experimental system described in this article involves in vitro activation of HSCs on plastic, modeling liver damage, and thus induction of the differentiation program reversibly converting these cells to myofibroblast-like cells. This differentiation is associated with the loss of cellular retinoid content, resulting in production of ATRA, critical to Foxp3 upregulation and Treg derivation. Because HSCs have been described as a-SMAexpressing activated cells during HCV infection (48, 49) , in response to ischemia/reperfusion injury (50) , and liver transplantation (51), this mechanism likely applies more to these scenarios involving liver damage than to steady-state oral tolerance, during which HSCs remain quiescent. Importantly, the finding that HSCs can influence Treg differentiation may explain the observations of increased Treg frequency in blood and liver during chronic HCV infection (15) , which is implicated, on one hand, in impairment of the virus-specific T cell response (52, 53) and, on the other hand, limitation of liver fibrosis (54) .
Overall, these findings provide insight into the phenomenon of immunological tolerance, the understanding of which is essential for modulation of this phenomenon in the clinical setting. For instance, augmentation of immunosuppression using HSC-targeted methods may enhance the acceptance of liver transplants and may potentially extend beyond the liver, where Tregs may be used to prevent autoimmunity, allergy, or rejection of nonliver transplants. In contrast, inhibition of HSC-mediated Treg derivation may allow the immune system to clear HBV and HCV infections during the acute phase, before the onset of fibrosis and cirrhosis. Although methods for the direct targeting of HSCs remain under development, this study provides an important advance in the understanding of liver immunobiology and a potential target for the treatment of immune-related liver diseases.
